Please sign in to follow a disease.

CBNPC cancer

Clinical trials for CBNPC cancer explained in plain language.

Never miss a new study

Get alerted when new CBNPC cancer trials appear

Sign up with your email to follow new studies for CBNPC cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Lung cancer immunotherapy trial pulled before it began

Disease control Cancelled

This study was designed to test two immunotherapy drugs, atezolizumab and tiragolumab, in people with advanced lung cancer that has special immune cell clusters called tertiary lymphoid structures. The trial was withdrawn before enrolling any participants, so no results are avail…

Matched conditions: CBNPC CANCER

Phase 2 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control

Last updated Jun 27, 2026 12:00 UTC

CBNPC cancer

Get alerted when new CBNPC cancer trials appear

Lung cancer immunotherapy trial pulled before it began